Healthcare Sector

TM Capital has developed in-depth healthcare sector expertise by completing the many transactions listed below for clients who are leaders across a range of healthcare disciplines.

Fleet Amends Senior Credit Facility
TM Capital advised C.B. Fleet in completing an amended senior credit facility
Review Transaction


MedTech Completes Recapitalization
TM Capital assisted The MedTech Group in completing a recapitalization with KRG Capital Partners to accelerate growth and provide shareholder liquidity
Review Transaction


Dinex Acquired by Carlisle Companies
TM Capital advised Dinex Holdings, a provider of specialty foodservice products to healthcare markets, in its $95 million sale to Carlisle Companies (NYSE), a $2 billion diversified global manufacturer
Review Transaction


Immucor Acquires BioArray Solutions
TM Capital advised Immucor, Inc. (NASDAQ) on its $117 million acquisition of BioArray Solutions Ltd.
Review Transaction


Immucor Forms Joint Venture with Kainos
TM Capital assisted Immucor, Inc. (NASDAQ) in forming a joint venture for distribution of Immucor's products in Japan with Kainos Laboratories, Inc.
Review Transaction


Immucor Acquires Gamma Biologicals
TM Capital assisted Immucor, Inc. (NASDAQ) in completing the $30 million acquisition of Gamma Biologicals, Inc. (AMEX) via a cash tender offer
Review Transaction


SteriGenics Acquired by IBA
TM Capital completed the sale of SteriGenics International, Inc. (NASDAQ) to Ion Beam Applications s.a. of Belgium for $214 million in cash
Review Transaction


SteriGenics Acquires Nicolet from Thermo
TM Capital assisted SteriGenics International, Inc. (NASDAQ) in acquiring Nicolet Electron Services from the Thermo-Electron Group (NYSE)
Review Transaction


Portland Professional Acquired by NMHC
TM Capital completed the sale of Portland Professional Pharmacy to National Medical Health Card Systems, Inc. (NASDAQ)
Review Transaction


Jensen Completes Recapitalization
TM Capital assisted Jensen Industries Inc. in completing a recapitalization transaction
Review Transaction


Heico Sells Meditek to U.S. Diagnostic Labs
TM Capital completed the $23 million sale by Heico Corporation (NYSE) of its Meditek Health division to U.S. Diagnostic Labs, Inc. (NASDAQ)
Review Transaction


Medical Diagnostics Acquired by ANMR
TM Capital completed the $29 million sale of Medical Diagnostics, Inc. (NASDAQ) to Advanced NMR Systems Inc. (NASDAQ) following an unsolicited tender offer by Raytel Medical Corp. (NASDAQ)
Review Transaction


Medcom Acquired by Quintiles
TM Capital completed the sale of Medcom, Inc. to Quintiles Transnational Corp. (NASDAQ)
Review Transaction


Armstrong Pharma Acquired by Medeva
TM Capital advised Armstrong Pharmaceuticals, Inc. (NASDAQ) in completing its $52 million stock swap merger with Medeva plc (LSE)
Review Transaction


International Murex Completes Financing
TM Capital arranged $15 million of senior debt financing for International Murex Technologies Corporation (NASDAQ)
Review Transaction


Immucor Acquires Division of Biopool
TM Capital assisted Immucor, Inc. (NASDAQ) in the acquisition of the BCA division of Biopool International, Inc. (NASDAQ)
Review Transaction


Immucor Completes Debt Restructuring
TM Capital assisted Immucor, Inc. (NASDAQ) in restructuring $42 million of senior indebtedness
Review Transaction


Immucor Board of Directors Re-Elected
TM Capital advised the Board of Directors of Immucor, Inc.(NASDAQ) in connection with a proxy contest in which all of Immucor's directors were successfully re-elected
Review Transaction


Immucor Goodwill Valuation Analysis
TM Capital provided Immucor, Inc. (NASDAQ) with an analysis of goodwill balances for potential impairment pursuant to FAS 142
Review Transaction


SteriGenics Acquires Irradiation Industries
TM Capital assisted SteriGenics International, Inc. (NASDAQ) in the strategic acquisition of Irradiation Industries, Inc.
Review Transaction


SteriGenics Int'l Acquires RTI
TM Capital assisted SteriGenics International, Inc. (NASDAQ) in acquiring the business and assets of RTI, Inc.
Review Transaction


BioLok Acquired by Healthpoint Capital
TM Capital rendered a fairness opinion to the Board of Directors of BioLok International Inc. (OTC) with respect to the sale of BioLok to Healthpoint Capital
Review Transaction